Pericytes may have an important role in the pathogenesis of vascular malformations

Medical Hypotheses

Volumn 68, Issue 4, 2007, Pages 808-810

  Li, Chen ^a   Zhang, Wen Feng ^a   Zhao, Yi Fang ^a,b  

^a WUHAN UNIVERSITY   (China)

^b Wuhan University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL COUNT; CELL FUNCTION; CONGENITAL BLOOD VESSEL MALFORMATION; HYPOTHESIS; PATHOGENESIS; PERICYTE; PRIORITY JOURNAL;

ABNORMALITIES; ANIMALS; CARDIOVASCULAR ABNORMALITIES; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; HUMANS; MICROCIRCULATION; MODELS, BIOLOGICAL; PERICYTES; SIGNAL TRANSDUCTION; VASCULAR DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846354504     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.09.010     Document Type: Article

References (20)

1. Waner M., and Suen J.Y. Hemangiomas and vascular malformations of the head and neck (1999), Wiley-Liss Inc., New York P.93-149
2. Eerola I., Boon L.M., Watanabe S., et al. Locus for susceptibility for familial capillary malformation ('port-wine stain') maps to 5q. Eur J Hum Genet 10 (2002) 375-380
3. Vikkula M., Boon L.M., Carraway III K.L., et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87 (1996) 1181-1190
4. Brouillard P., and Vikkula M. Vascular malformations: Localized defects in vascular morphogenesis. Clin Genet 63 (2003) 340-351
5. Wakhloo A.K., Lieber B.B., Siekmann R., et al. Acute and chronic swine rete arteriovenous malformation models: Hemodynamics and vascular remodeling. AJNR Am J Neuroradiol 26 (2005) 1702-1706
6. August P., and Suthanthiran M. Transforming growth factor beta signaling, vascular remodeling, and hypertension. N Engl J Med 354 (2006) 2721-2723
7. D'Amore P.A. Capillary growth: A two-cell system. Semin Cancer Biol 3 (1997) 49-56
8. Hellstrom M., Kalen M., Lindahl P., et al. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126 (1999) 3047-3055
9. Shih S.C., Ju M., Liu N., et al. Transforming growth factor β1 induction of vascular endothelial growth factor receptor 1: Mechanism of pericyte-induced vascular survival in vivo. Proc Natl Acad Sci USA 100 (2003) 15859-15864
10. Benjamin L.E., Golijanin D., Itin A., et al. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103 (1999) 159-165
11. Folkman J., and D'Amore P.A. Blood vessel formation: What is its molecular basis?. Cell 87 (1996) 1153-1155
12. Reinmuth N., Liu W., Jung Y.D., et al. Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J 15 (2001) 1239-1241
13. Suri C., Jones P.F., Patan S., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87 (1996) 1171-1180
14. Vikkula M., Boon L.M., Carraway K.L., et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87 (1996) 1181-1190
15. Hellstrom M., Gerhardt H., Kalen M., et al. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153 (2001) 543-553
16. Brands M.W., and Granger J.P. Control of renal function and blood pressure by angiotensin II: Implications for diabetic glomerular injury. Miner Electrolyte Metab 24 (1998) 371-380
17. Hammes H.P., Lin J.H., Renner O., et al. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 51 (2002) 3107-3112
18. Bertossi M., Virgintino D., Maiorano E., et al. Ultrastructural and morphometric investigation of human brain capillaries in normal and peritumoral tissues. Ultrastruct Pathol 21 (1997) 41-49
19. Berger M., Bergers G., Arnold B., et al. Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization. Blood 105 (2005) 1094-1101
20. Erber R., Thurnher A., Katsen A.D., et al. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. FASEB J 18 (2004) 338-340